Literature DB >> 1691843

Symptoms and signs of prostatism as risk factors for prostatectomy.

H M Arrighi1, H A Guess, E J Metter, J L Fozard.   

Abstract

Symptom questionnaires and physical examinations administered periodically to 1,057 men followed prospectively for up to 30 years in the Baltimore Longitudinal Study of Aging (BLSA) were analyzed to determine which symptoms of prostatism were predictive of subsequent prostatectomy for benign prostatic hyperplasia (BPH). Change in the size and force of the urinary stream (P = 0.0001) and a sensation of incomplete emptying (P = 0.0005) were the only symptoms positively predictive in a multivariate analysis. Prostate enlargement by rectal palpation was an independent risk factor for prostatectomy (P less than 0.03) and was associated with hesitancy (P less than 0.02) and a sensation of incomplete emptying (P less than 0.02). Of the men with all three risk factors, 37% (41/112) eventually had a prostatectomy, in contrast to 8% of the remaining 945 men. This is the first study to document the extent to which urologic symptoms and a digital rectal examination predict subsequent prostatectomy for BPH.

Entities:  

Mesh:

Year:  1990        PMID: 1691843     DOI: 10.1002/pros.2990160309

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Sexual Function and alpha-Blockers.

Authors:  Kevin T McVary
Journal:  Rev Urol       Date:  2005

2.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

3.  Free-beam and contact laser ablation of benign prostatic hyperplasia with the KTP/Nd:YAG laser: efficacy and versatility.

Authors:  M J Manyak; G P Aulisi
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy.

Authors:  Yan Kit Fong; Sibylle Marihart; Mike Harik; Bob Djavan
Journal:  Rev Urol       Date:  2004

5.  Reducing the risk of benign prostatic hyperplasia progression.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2002

6.  Benign prostatic hyperplasia: does prostate size matter?

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2003

7.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

Authors:  H B Carter; J D Pearson; E J Metter; L J Brant; D W Chan; R Andres; J L Fozard; P C Walsh
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

8.  Effects of running distance and performance on incident benign prostatic hyperplasia.

Authors:  Paul T Williams
Journal:  Med Sci Sports Exerc       Date:  2008-10       Impact factor: 5.411

Review 9.  Fact or fiction: what do the benign prostatic hyperplasia data tell us?

Authors:  Majid Shabbir; Roger S Kirby
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

Review 10.  Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients.

Authors:  J S Lam; M A Volpe; S A Kaplan
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.